These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3751419)

  • 41. [Effect of corglycon and cavinton on the hemodynamics of patients with initial manifestations of insufficiency of cerebral circulation].
    Ishchenko MM; Nechaĭ EE
    Vrach Delo; 1988 May; (5):53-5. PubMed ID: 3420871
    [No Abstract]   [Full Text] [Related]  

  • 42. [Experimental studies on the effect of 2-diethylamino-5-phenyl-4-oxazolinone (Ha94) on the electroencephalogram of epileptics].
    Jovanović UJ
    Arztl Forsch; 1966 Feb; 20(2):98-103. PubMed ID: 4963892
    [No Abstract]   [Full Text] [Related]  

  • 43. [About cavinton therapy of the patients with brain vascular diseases].
    Nikitina VV; Pravdina AN; Zapatrina OV
    Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611
    [No Abstract]   [Full Text] [Related]  

  • 44. [Cavinton treatment of patients with chronic cerebral circulatory insufficiency].
    Ishchenko MM; Shkrobot SI; Ishchenko AM
    Vrach Delo; 1986 Apr; (4):51-4. PubMed ID: 3716339
    [No Abstract]   [Full Text] [Related]  

  • 45. EEG/fMRI study of ictal and interictal epileptic activity: methodological issues and future perspectives in clinical practice.
    Di Bonaventura C; Vaudano AE; Carnì M; Pantano P; Nucciarelli V; Garreffa G; Maraviglia B; Prencipe M; Bozzao L; Manfredi M; Giallonardo AT
    Epilepsia; 2006; 47 Suppl 5():52-8. PubMed ID: 17239107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Possibilities of cavinton therapy regimen for infusions and cavinton comforte in acute and early recovery periods after ischemic stroke].
    Belova LA; Mashin VV; Proshin AN; Ovsyannicova AN; Kostishko BB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):51-58. PubMed ID: 29053121
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Initial dyscirculatory encephalopathy in middle-aged and elderly patients (problems of early diagnosis and therapy)].
    Man'kovskiĭ NB; Mints AIa; Karaban' IN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(1):16-20. PubMed ID: 2718657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of cavinton on the indices of carbohydrate metabolism in the blood vessel wall].
    Turkova LA
    Farmakol Toksikol; 1988; 51(2):62-3. PubMed ID: 2454202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Cavinton in the treatment of ischemic cerebral stroke. Clinical and computerized-tomographic evaluation].
    Domzał T; Kozłowski P; Zaleska B
    Neurol Neurochir Pol; 1986; 20(3):234-40. PubMed ID: 3537828
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Action of Cavinton on hearing defects of different origin.
    Jasper A
    Ther Hung; 1978; 26(4):181-4. PubMed ID: 751275
    [No Abstract]   [Full Text] [Related]  

  • 51. Use of Cavinton drip infusion in ophthalmology. II. Effect of Cavinton drip infusion in eye diseases caused by vascular occlusion or stenosis.
    Imre G
    Ther Hung; 1986; 34(2):84-6. PubMed ID: 3449973
    [No Abstract]   [Full Text] [Related]  

  • 52. Observations with Cavinton (RGH-4405).
    Alberth B; Somogyi E
    Ther Hung; 1979; 27(1):17-27. PubMed ID: 494138
    [No Abstract]   [Full Text] [Related]  

  • 53. [The effect of kavinton and korglycon on the central and cerebral hemodynamics of patients with an ischemic stroke in stenoses and occlusions of the major cerebral arteries].
    Ishchenko MM; Korol'kov OS
    Lik Sprava; 1998 Aug; (6):120-4. PubMed ID: 9844895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Examination of Cavinton effect in elderly diabetic patients.
    Boda J; Karsay K; Czakó L; Fügi S; Kovács A; Koncz I; Maczkó PA
    Ther Hung; 1989; 37(3):176-80. PubMed ID: 2588202
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vasodilating effect of ethyl apovincaminate on conjunctival vessels and simultaneous observation of parameters indicating adverse effect.
    Brooser G; Anda L; Domán J
    Arzneimittelforschung; 1976; 26(10a):1975-7. PubMed ID: 1037227
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Mechanisms of emergency adaptation of the erythron system to hypoxia in rats receiving cavinton].
    Morshchakova EF; Krokhotina LV
    Patol Fiziol Eksp Ter; 1991; (5):9-11. PubMed ID: 1806900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of cavinton on the hemorheological parameters of chronic cerebrovascular patients].
    Sapary L; Horvath B; Alexy T; Marton Z; Kesmarky G; Zsots M; Nagy F; Czopf I; Toth K
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(6):47-51. PubMed ID: 16841484
    [No Abstract]   [Full Text] [Related]  

  • 58. [Use of the Soviet preparation methindione for injections in convulsive conditions].
    Lapin AA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(7):1084-9. PubMed ID: 961295
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The results of clinical study of cavinton efficacy inpatients with chronic brain ischemia].
    Doronin BM; Popova TF; Kornach NV; Klimova LA; Volkova II; Chelysheva LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):48-50. PubMed ID: 19253466
    [No Abstract]   [Full Text] [Related]  

  • 60. [Cavinton in the complex treatment of patients with chronic cerebrovascular insufficiency].
    Chukanova EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(9):35-9. PubMed ID: 19770831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.